Pharmiva AB Performance
Pharmiva Relative Risk vs. Return Landscape
If you would invest (100.00) in Pharmiva AB on September 19, 2024 and sell it today you would earn a total of 100.00 from holding Pharmiva AB or generate -100.0% return on investment over 90 days. Pharmiva AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Pharmiva, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pharmiva Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmiva's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharmiva AB, and traders can use it to determine the average amount a Pharmiva's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PHARM |
Based on monthly moving average Pharmiva is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmiva by adding Pharmiva to a well-diversified portfolio.
Things to note about Pharmiva AB performance evaluation
Checking the ongoing alerts about Pharmiva for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharmiva AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmiva AB is not yet fully synchronised with the market data | |
| Pharmiva AB has some characteristics of a very speculative penny stock |
- Analyzing Pharmiva's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmiva's stock is overvalued or undervalued compared to its peers.
- Examining Pharmiva's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmiva's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmiva's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmiva's stock. These opinions can provide insight into Pharmiva's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Pharmiva Stock
If you are still planning to invest in Pharmiva AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmiva's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |